1. Home
  2. RPM vs ROIV Comparison

RPM vs ROIV Comparison

Compare RPM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPM International Inc.

RPM

RPM International Inc.

HOLD

Current Price

$107.31

Market Cap

13.8B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$20.84

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPM
ROIV
Founded
1947
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Paints/Coatings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8B
14.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RPM
ROIV
Price
$107.31
$20.84
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$128.50
$21.19
AVG Volume (30 Days)
821.2K
7.9M
Earning Date
01-06-2026
11-10-2025
Dividend Yield
1.90%
N/A
EPS Growth
12.29
N/A
EPS
5.36
N/A
Revenue
$7,517,598,000.00
$20,329,000.00
Revenue This Year
$6.95
N/A
Revenue Next Year
$3.37
$320.50
P/E Ratio
$20.03
N/A
Revenue Growth
3.09
N/A
52 Week Low
$95.28
$8.73
52 Week High
$140.41
$21.35

Technical Indicators

Market Signals
Indicator
RPM
ROIV
Relative Strength Index (RSI) 48.42 68.70
Support Level $101.75 $19.99
Resistance Level $108.07 $20.99
Average True Range (ATR) 2.03 0.68
MACD 0.54 -0.14
Stochastic Oscillator 78.72 71.47

Price Performance

Historical Comparison
RPM
ROIV

About RPM RPM International Inc.

RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue is from the construction products and North America.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: